Clinical Trial Update: GA YAZ ACNE in China Phase III [Phase 3]

View source ↗

Summary

Bayer completed a Phase III trial in China evaluating GA YAZ ACNE for acne vulgaris, with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• GA YAZ ACNE (drospirenone and ethinyl estradiol)

Snippet

Sponsor: Bayer | Conditions: Acne Vulgaris | Phase 3 | Status: COMPLETED | Results posted: 2011-06-09